Recombinant multi-species Caspase 9/p35/p10/CASP9 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine Caspase 9/p35/p10/CASP9 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a member of the cysteine-aspartic acid protease (caspase) family. Sequential activation of caspases plays a central role in the execution-phase of cell apoptosis. Caspases exist as inactive proenzymes which undergo proteolytic processing at conserved aspartic residues to produce two subunits, large and small, that dimerize to form the active enzyme. This protein can undergo autoproteolytic processing and activation by the apoptosome, a protein complex of cytochrome c and the apoptotic peptidase activating factor 1; this step is thought to be one of the earliest in the caspase activation cascade. This protein is thought to play a central role in apoptosis and to be a tumor suppressor. Alternative splicing results in multiple transcript variants. [provided by RefSeq, May 2013]
The Alternative Names of target: APAF-3,APAF3,Apaf3,Apoptotic protease Mch-6,Apoptotic protease-activating factor 3 (APAF-3),CASP-9,CASP9,Casp-9-CTD,Casp9,Casp9_v1,Caspase 9,Caspase-9,ICE-LAP6,ICE-like apoptotic protease 6 (ICE-LAP6),Ice-Lap6,MCH6,Mch6,PPP1R56,p10,p35
Go
to Caspase 9/p35/p10/CASP9 products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-T93903-Ag-1/ GM-Tg-hg-T93903-Ag-2 | Human Caspase 9/p35/p10/CASP9 protein | Human |
| GM-Tg-rg-T93903-Ag-1/ GM-Tg-rg-T93903-Ag-2 | Rat Caspase 9/p35/p10/CASP9 protein | Rat |
| GM-Tg-mg-T93903-Ag-1/ GM-Tg-mg-T93903-Ag-2 | Mouse Caspase 9/p35/p10/CASP9 protein | Mouse |
| GM-Tg-cynog-T93903-Ag-1/ GM-Tg-cynog-T93903-Ag-2 | Cynomolgus/Rhesus macaque Caspase 9/p35/p10/CASP9 protein | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-T93903-Ag-1/ GM-Tg-felg-T93903-Ag-2 | Feline Caspase 9/p35/p10/CASP9 protein | Feline |
| GM-Tg-cang-T93903-Ag-1/ GM-Tg-cang-T93903-Ag-2 | Canine Caspase 9/p35/p10/CASP9 protein | Canine |
| GM-Tg-bovg-T93903-Ag-1/ GM-Tg-bovg-T93903-Ag-2 | Bovine Caspase 9/p35/p10/CASP9 protein | Bovine |
| GM-Tg-equg-T93903-Ag-1/ GM-Tg-equg-T93903-Ag-2 | Equine Caspase 9/p35/p10/CASP9 protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. |
GM-Tg-hg-T93903-Ag-1/ GM-Tg-hg-T93903-Ag-2;
GM-Tg-rg-T93903-Ag-1/ GM-Tg-rg-T93903-Ag-2;
GM-Tg-mg-T93903-Ag-1/ GM-Tg-mg-T93903-Ag-2; GM-Tg-cynog-T93903-Ag-1/ GM-Tg-cynog-T93903-Ag-2; GM-Tg-felg-T93903-Ag-1/ GM-Tg-felg-T93903-Ag-2; GM-Tg-cang-T93903-Ag-1/ GM-Tg-cang-T93903-Ag-2; GM-Tg-bovg-T93903-Ag-1/ GM-Tg-bovg-T93903-Ag-2; GM-Tg-equg-T93903-Ag-1/ GM-Tg-equg-T93903-Ag-2 |
| Products Name | Caspase 9/p35/p10/CASP9 protein |
| Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
| Target Name | Caspase 9/p35/p10/CASP9 |
| Protein Sub-location | Introcelluar Protein |
| Isotypes | Recombinant protein |
| Expression platform | Mammalian cell |
| Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
| Tag | His |
| Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine Caspase 9/p35/p10/CASP9 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab

GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.